We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current SWTX market cap is 3.33B. The company's latest EPS is USD -4.4060 and P/E is -10.24.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -73.23M | -79.13M | -78.98M | -83.75M | -85.02M |
| Net Income | -72.39M | -74.18M | -73.42M | -77.93M | -79.44M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 35M | 0 | 0 | 5.45M |
| Operating Income | -61.85M | -46.93M | -174.46M | -283.56M | -348.05M |
| Net Income | -50.58M | -45.57M | -173.91M | -277.42M | -325.1M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 681.55M | 630.24M | 569.2M | 517.33M | 467.65M |
| Total Liabilities | 69.15M | 72.05M | 62.27M | 65.89M | 72.76M |
| Total Equity | 612.4M | 558.19M | 506.92M | 451.44M | 394.9M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 334.83M | 576.19M | 452.49M | 630.24M | 725.79M |
| Total Liabilities | 12.76M | 19.13M | 30.1M | 72.05M | 99.57M |
| Total Equity | 322.07M | 557.06M | 422.4M | 558.19M | 626.22M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -107.36M | -161.56M | -61.82M | -109.63M | -160.09M |
| Investing | 139.41M | -215.6M | 98.6M | 159.36M | 193.96M |
| Financing | 340.4M | 340.7M | -1.85M | -2.19M | -2.43M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -47.44M | -32.19M | -127.88M | -161.56M | -222.8M |
| Investing | -4.26M | -418.83M | 83.59M | -215.6M | 34.75M |
| Financing | 333.71M | 270.49M | 1.16M | 340.7M | 296.64M |
| Market Cap | 3.33B |
| Price to Earnings Ratio | -10.24 |
| Price to Sales Ratio | 611.25 |
| Price to Cash Ratio | 18.91 |
| Price to Book Ratio | 5.32 |
| Dividend Yield | - |
| Shares Outstanding | 73.79M |
| Average Volume (1 week) | 1.51M |
| Average Volume (1 Month) | 935.64k |
| 52 Week Change | 93.52% |
| 52 Week High | 53.92 |
| 52 Week Low | 18.00 |
| Spread (Intraday) | 17 (36.17%) |
| Company Name | SpringWorks Therapeutics Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.springworkstx.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
